Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by Thor6570on Sep 17, 2020 9:05am
403 Views
Post# 31573319

Is Theralase CFO overpaid ?

Is Theralase CFO overpaid ?The best I could identify i9s potentially 36 employees , however it is not clear if this has increased or diminished this past year. 

Theralase Technologies Inc. Management | Theralase Technologies Inc. Employees

W
ith this being said our CFO is being paid $300 k per year with horrible results to date. Laser sales are in the toilet ( covid ) and Theralase Clinical trial is as well not progressing as no new patients have been announced as treated. So whay are we paying our CFO more than double the average Canadaina CFO ???? Somthing is not right here and needs correction. 

What does a CFO of a small company make?
A mid-career Chief Financial Officer (CFO) with 5-9 years of experience earns an average total compensation of C$120,772 based on 132 salaries. An experienced Chief Financial Officer (CFO) with 10-19 years of experience earns an average total compensation of C$134,008 based on 391 salaries.May 26, 2020
 

Bullboard Posts